Tracking a blood marker in children with lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study checks whether measuring a blood test called “circulating tumor DNA” (ctDNA) helps monitor childhood lymphoma during treatment. It’s meant to see if ctDNA tracking can provide useful information alongside standard exams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 and have pediatric lymphoma (either Hodgkin lymphoma or non-Hodgkin lymphoma).
- Your energy/ability score from ECOG is 0 to 2 (meaning you can do daily activities with limited help).
- Your doctors have found at least one measurable lymph node/lesion on CT or MRI (at least 1.5 cm) that can be measured more than one way.
- You can provide required blood samples (and any needed tissue/bone marrow/cerebrospinal fluid samples) at the start and throughout follow-up.
- All needed baseline test results and pathology (tissue diagnosis details) are available, and you can be evaluated on schedule.
- You (or your legal parent/guardian) can sign informed consent after learning about the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to monitor how well your lymphoma treatment is working. It uses a blood test to look for genetic changes in cancer cells, which may help doctors make better treatment decisions.
This study collects blood samples from neuroblastoma patients to test for tiny pieces of tumor DNA that can show how well treatment is working. By tracking these markers over time, doctors hope to better predict how patients will respond and improve care.
This study uses a blood test to detect cancer DNA (ctDNA) in children and young adults with classical Hodgkin lymphoma. The goal is to see if this non-invasive test can help track how well treatment is working.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
This study looks at “biomarkers” (measurable signs in your tumor and possibly blood) to understand your lymphoma’s genetic make-up. The goal is to see which markers may help doctors decide on treatment and timing.
This study looks at whether a blood test that checks for tiny pieces of tumor DNA (called ctDNA) can help predict how Hodgkin lymphoma will progress. It is for adults who have just been diagnosed with classical Hodgkin lymphoma.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.